As the understanding of fenofibrate's mechanism becomes clearer and its safety profile more widely recognized, we anticipate its role in the management of dyslipidemia to increase. This is ...

Fenofibrate 67mg, 134mg, 200mg; caps (micronized). Adjunct to diet: in severe hypertriglyceridemia; and to reduce elevated total-C, LDL-C, ApoB, and TG, and to increase HDL-C in primary ...

Adjunct to diet: in severe hypertriglyceridemia; and to reduce elevated total-C, LDL-C, ApoB, and TG, and to increase HDL-C in primary hyperlipidemia and mixed dyslipidemia. Take with food ...

After 4 weeks' lead-in, participants received LY518674 (10, 25, 50 or 100 µg), fenofibrate (200 mg) or placebo for 12 weeks. In the second study, LY518674, with or without atorvastatin ...

Fenofibrate and its active metabolite, fenofibric acid, are primarily excreted by the kidneys. It is nondialysable, and studies in patients with moderate chronic kidney disease (GFR <50 ml/min/1. ...